Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy

F Rishi1, J E Hulse, D O Auld

  • 1Children's Heart Center, Egleston Children's Hospital, Emory University, Atlanta, Georgia 30328, USA.

Insights

Dual-chamber pacing (DCP) effectively treats pediatric hypertrophic obstructive cardiomyopathy (HOCM) by reducing outflow tract gradients and improving symptoms. This therapy is beneficial for selected children unresponsive to medication.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Electrophysiology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart condition causing left ventricular outflow tract (LVOT) obstruction.
  • Medications are often insufficient for symptomatic pediatric HOCM.
  • Dual-chamber pacing (DCP) has shown promise in adults with HOCM.

Purpose of the Study:

  • To evaluate the efficacy of temporary and permanent dual-chamber pacing (DCP) in pediatric patients with hypertrophic obstructive cardiomyopathy (HOCM).
  • To assess the impact of DCP on left ventricular outflow tract (LVOT) gradients and patient symptoms.

Main Methods:

  • Ten pediatric patients (age 1-17.5 years) with HOCM and LVOT gradient >= 40 mm Hg were studied.
  • Temporary pacing was assessed during cardiac catheterization.
  • Seven patients with hemodynamic improvement underwent permanent DCP implantation and were followed with questionnaires, Doppler, treadmill tests, and repeat catheterization.

Main Results:

  • Temporary pacing showed significant reduction in LVOT gradient, left ventricular systolic pressure, and pulmonary capillary wedge pressure in 70% of patients.
  • Permanent DCP led to significant symptom improvement (dyspnea, exercise intolerance) and sustained reduction in LVOT gradient at follow-up (23 months).
  • Congenital mitral valve abnormalities and rapid atrial rates were identified as factors precluding effective pacing in some patients.

Conclusions:

  • Permanent dual-chamber pacing (DCP) is an effective treatment for selected pediatric patients with hypertrophic obstructive cardiomyopathy (HOCM).
  • Careful patient selection is crucial, as certain conditions like congenital mitral valve abnormalities can limit pacing effectiveness.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...